Deferred Tax Assets, Gross of Perspective Therapeutics, Inc. from 30 Jun 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Perspective Therapeutics, Inc. quarterly Deferred Tax Assets, Gross in USD history and change rate from 30 Jun 2011 to 31 Dec 2024.
  • Perspective Therapeutics, Inc. Deferred Tax Assets, Gross for the quarter ending 31 Dec 2024 was $50,834,000, a 31% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

Perspective Therapeutics, Inc. Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $50,834,000 +$12,006,000 +31% 31 Dec 2024 10-K/A 28 Mar 2025 2024 FY
Q4 2023 $38,828,000 +$18,239,000 +89% 31 Dec 2023 10-K/A 28 Mar 2025 2024 FY
Q4 2022 $20,589,000 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q2 2022 $19,074,000 +$1,428,000 +8.1% 30 Jun 2022 10-KT 01 May 2023 2023 Q1
Q2 2021 $17,646,000 +$659,000 +3.9% 30 Jun 2021 10-KT 01 May 2023 2023 Q1
Q2 2020 $16,987,000 +$739,000 +4.5% 30 Jun 2020 10-K 27 Sep 2021 2021 FY
Q2 2019 $16,248,000 +$1,228,000 +8.2% 30 Jun 2019 10-K 25 Sep 2020 2020 FY
Q2 2018 $15,020,000 -$7,703,000 -34% 30 Jun 2018 10-K 27 Sep 2019 2019 FY
Q2 2017 $22,723,000 +$2,123,000 +10% 30 Jun 2017 10-K 26 Sep 2018 2018 FY
Q2 2016 $20,600,000 +$1,675,000 +8.9% 30 Jun 2016 10-K 28 Sep 2017 2017 FY
Q2 2015 $18,925,000 +$1,389,761 +7.9% 30 Jun 2015 10-K 09 Sep 2016 2016 FY
Q2 2014 $17,535,239 +$1,736,327 +11% 30 Jun 2014 10-K 14 Sep 2015 2015 FY
Q2 2013 $15,798,912 +$1,257,494 +8.6% 30 Jun 2013 10-K 29 Sep 2014 2014 FY
Q2 2012 $14,541,418 +$1,467,966 +11% 30 Jun 2012 10-K 30 Sep 2013 2013 FY
Q2 2011 $13,073,452 30 Jun 2011 10-K/A 26 Oct 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.